TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.17, no.2, pp.123-127, 2020 (ESCI)
Objective: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer.